Reuters logo
BRIEF-Cytodyn's Pro 140 for treating HIV deemed too broad for orphan drug designation by FDA
April 17, 2017 / 10:22 AM / 7 months ago

BRIEF-Cytodyn's Pro 140 for treating HIV deemed too broad for orphan drug designation by FDA

April 17 (Reuters) - Cytodyn Inc

* Potential for Cytodyn’s PRO 140 for treating HIV patients deemed too broad for orphan drug designation by the FDA

* Cytodyn Inc - application for orphan drug designation not granted by office of orphan products development of U.S. Food and Drug Administration (FDA) Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below